Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications. - Wikidata - wikimedia - TriplyDB

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.

http://www.wikidata.org/entity/Q30817266

about

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Optimal therapy of type 2 diabetes: a controversial challenge Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.Optimizing combination treatment in the management of type 2 diabetes The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Variations in tissue selectivity amongst insulin secretagogues: a systematic review.Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies.Insulin-secretagogue activity of p-methoxycinnamic acid in rats, perfused rat pancreas and pancreatic beta-cell line.Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes.Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case-control study.Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

P2860

Q22241288-122B420E-3B5D-4F8F-BF38-1ED5F0157C82 Q30234356-CD1529BA-8681-4F3C-AD69-B5915176AE02 Q33577712-6DBD597C-0C07-4BB7-BF5D-B92EE9385134 Q34257350-AA9D3C88-FACC-49D3-8CD0-6BC1B856BCE3 Q36536205-9273C7C9-D0BE-4A2B-BD41-2EB9A8AD8649 Q36679594-57EBEDFF-BCB5-486F-8B5E-269EC2A6FCDC Q36782688-D0531CB8-EF30-4ED4-8563-632809B1D6B5 Q37031367-0E0D7813-3A3B-4E8E-9C6B-8D67DD432C15 Q37926558-A70600BE-834B-42F4-BD2C-AE1FF290D58B Q37933466-8CD66C03-8E16-4D88-9E98-3D08C76E8B9F Q38364806-50852DBF-C9FE-433B-AB51-33A661CEFD82 Q38607502-CE5D0D95-A27E-4231-9802-0D385E582409 Q40001695-3DB41DC6-F6E4-4739-9CCA-DC25C5A843E1 Q40787120-DC93BD57-CAA0-40F4-9ADA-366DCD1BA615 Q43901204-E789E049-7B8C-4295-932C-F25A7ACEF01A Q50043733-3AF01371-5DF0-4050-B2E3-197ACE9F63B5 Q51334840-BE3EFDBB-3EB4-4351-8409-8D5A67A559B1 Q51498513-BC9D639A-6B36-4BD5-B9FA-9C0CB08353B2 Q57412648-E4C42CAD-9F57-4EAB-B456-254224A80AE5

P2860

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.

http://www.wikidata.org/entity/Q30817266

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@ast

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@en

type

label

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@ast

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@en

prefLabel

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@ast

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@en

P1433

Q30817266-D19F657D-B8A5-4528-9A06-E65F5E57D3CF

P1476

Q30817266-D6BB282A-E70D-4F86-B233-355B3B4B39E7

P2093

Q30817266-171AD740-68DA-4169-BD2D-8D4FA108D26E

Q30817266-60EFB34A-7C2B-4FF4-A646-055027F68CCD

Q30817266-9AC24579-8341-4169-997D-C28DB21540BB

Q30817266-AE64294D-1624-468C-AEB4-22DBF9256DD7

Q30817266-CBE14B1E-50B9-442C-A182-C0D1040C59C9

P304

Q30817266-2685655F-4BF8-4B19-B1BF-77B1F4CC7B2A

P31

Q30817266-2472D91D-F2B2-4095-AAF5-81B8462B0CE0

P356

Q30817266-4F94F339-F75A-4C6E-BC84-69D5F80204C0

P433

Q30817266-D4620653-7B45-46FD-A794-6E6D09EED66E

P478

Q30817266-7ED7624E-4AE9-48DB-81FD-79362A1B5FA2

P577

Q30817266-D7BA9C8E-8E77-4344-A1A2-1F3ECB0F2EBF

P5875

Q30817266-3204ECCB-C855-4EBF-BD86-98647F9B8CD9

P698

Q30817266-EE60F2AE-A3B2-41E3-85A6-03C1572FFBB0

P356

S1262-3636(07)70030-7

P1433

Diabetes and Metabolism

P1476

Sulfonylureas and cardiovascul ...... ans and clinical applications.

@en

P2093

Charpentier G

http://www.w3.org/2001/XMLSchema#string

Danchin N

http://www.w3.org/2001/XMLSchema#string

Ledru F

http://www.w3.org/2001/XMLSchema#string

Riveline JP

http://www.w3.org/2001/XMLSchema#string

Varroud-Vial M

http://www.w3.org/2001/XMLSchema#string

P304

207-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1262-3636(07)70030-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10620291

http://www.w3.org/2001/XMLSchema#string

P698

12909809

http://www.w3.org/2001/XMLSchema#string